BACKGROUND: Renal transplant recipients (RTRs) have commonly been urged to limit their potassium intake during renal insufficiency and may adhere to this principle after transplantation. Importantly, in experimental animal models, low dietary potassium intake induces kidney injury through stimulation of ammoniagenesis. In humans, low potassium intake is an established risk factor for high blood pressure. OBJECTIVE: We hypothesized that low 24-h urinary potassium excretion [UKV; urinary potassium concentration × volume], the gold standard for assessment of dietary potassium intake, represents a risk factor for graft failure and mortality in RTRs. In secondary analyses, we aimed to investigate whether these associations could be explained by ammoniagenesis, plasma potassium, or blood pressure. DESIGN: In a prospective cohort of 705 RTRs, we assessed dietary potassium intake by a single 24-h UKV and food-frequency questionnaires. Cox regression analyses were used to investigate prospective associations with outcome. RESULTS: We included 705 stable RTRs (mean ± SD age: 53 ± 13 y; 57% men) at 5.4 y (IQR: 1.9-12.0 y) after transplantation and 253 kidney donors. Mean ± SD UKV was 73 ± 24 mmol/24 h in RTRs compared with 85 ± 25 mmol/24 h in kidney donors. During follow-up for 3.1 y (IQR: 2.7-3.9 y), 45 RTRs developed graft failure and 83 died. RTRs in the lowest sex-specific tertile of UKV (women, <55 mmol/24 h; men, <65 mmol/24 h) had an increased risk of graft failure (HR: 3.70; 95% CI: 1.64, 8.34) and risk of mortality (HR; 2.66; 95% CI: 1.53, 4.61), independent of potential confounders. In causal path analyses, 24-h urinary ammonia excretion, plasma potassium, and blood pressure did not affect these associations. CONCLUSIONS: Our results indicate that low UKV is associated with a higher risk of graft failure and mortality in RTRs. Specific attention for adequate potassium intake after transplantation seems warranted. This trial was registered at clinicaltrials.gov as NCT02811835.
BACKGROUND: Renal transplant recipients (RTRs) have commonly been urged to limit their potassium intake during renal insufficiency and may adhere to this principle after transplantation. Importantly, in experimental animal models, low dietary potassium intake induces kidney injury through stimulation of ammoniagenesis. In humans, low potassium intake is an established risk factor for high blood pressure. OBJECTIVE: We hypothesized that low 24-h urinary potassium excretion [UKV; urinary potassium concentration × volume], the gold standard for assessment of dietary potassium intake, represents a risk factor for graft failure and mortality in RTRs. In secondary analyses, we aimed to investigate whether these associations could be explained by ammoniagenesis, plasma potassium, or blood pressure. DESIGN: In a prospective cohort of 705 RTRs, we assessed dietary potassium intake by a single 24-h UKV and food-frequency questionnaires. Cox regression analyses were used to investigate prospective associations with outcome. RESULTS: We included 705 stable RTRs (mean ± SD age: 53 ± 13 y; 57% men) at 5.4 y (IQR: 1.9-12.0 y) after transplantation and 253 kidney donors. Mean ± SD UKV was 73 ± 24 mmol/24 h in RTRs compared with 85 ± 25 mmol/24 h in kidney donors. During follow-up for 3.1 y (IQR: 2.7-3.9 y), 45 RTRs developed graft failure and 83 died. RTRs in the lowest sex-specific tertile of UKV (women, <55 mmol/24 h; men, <65 mmol/24 h) had an increased risk of graft failure (HR: 3.70; 95% CI: 1.64, 8.34) and risk of mortality (HR; 2.66; 95% CI: 1.53, 4.61), independent of potential confounders. In causal path analyses, 24-h urinary ammonia excretion, plasma potassium, and blood pressure did not affect these associations. CONCLUSIONS: Our results indicate that low UKV is associated with a higher risk of graft failure and mortality in RTRs. Specific attention for adequate potassium intake after transplantation seems warranted. This trial was registered at clinicaltrials.gov as NCT02811835.
Authors: Adrian Post; Isidor Minović; Else van den Berg; Manfred L Eggersdorfer; Gerjan J Navis; Johanna M Geleijnse; Reinold O B Gans; Harry van Goor; Joachim Struck; Casper F M Franssen; Ido P Kema; Stephan J L Bakker Journal: Physiol Rep Date: 2018-04
Authors: Jelmer K Humalda; Stanley M H Yeung; Johanna M Geleijnse; Lieke Gijsbers; Ineke J Riphagen; Ewout J Hoorn; Joris I Rotmans; Liffert Vogt; Gerjan Navis; Stephan J L Bakker; Martin H de Borst Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958
Authors: K Borowczyk; J Piechocka; R Głowacki; I Dhar; Ø Midtun; G S Tell; P M Ueland; O Nygård; H Jakubowski Journal: J Intern Med Date: 2018-09-23 Impact factor: 8.989
Authors: Karin Boslooper-Meulenbelt; Olga Patijn; Marieke C E Battjes-Fries; Hinke Haisma; Gerda K Pot; Gerjan J Navis Journal: Nutrients Date: 2019-10-11 Impact factor: 5.717
Authors: J Casper Swarte; Rianne M Douwes; Shixian Hu; Arnau Vich Vila; Michele F Eisenga; Marco van Londen; António W Gomes-Neto; Rinse K Weersma; Hermie J M Harmsen; Stephan J L Bakker Journal: J Clin Med Date: 2020-02-01 Impact factor: 4.241
Authors: Stanley M H Yeung; Antonio W Gomes-Neto; Maryse C J Osté; Else van den Berg; Jenny E Kootstra-Ros; Jan Stephan F Sanders; Stefan P Berger; Juan Jesus Carrero; Martin H De Borst; Gerjan J Navis; Stephan J L Bakker Journal: Clin J Am Soc Nephrol Date: 2021-06-16 Impact factor: 10.614
Authors: Isidor Minović; Michele F Eisenga; Ineke J Riphagen; Else van den Berg; Jenny Kootstra-Ros; Anne-Roos S Frenay; Harry van Goor; Gerald Rimbach; Tuba Esatbeyoglu; Andy P Levy; Carlo A J M Gaillard; Johanna M Geleijnse; Manfred L Eggersdorfer; Gerjan J Navis; Ido P Kema; Stephan J L Bakker Journal: Sci Rep Date: 2017-10-27 Impact factor: 4.379
Authors: Sara Sokooti; Tamas Szili-Torok; Jose L Flores-Guerrero; Maryse C J Osté; António W Gomes-Neto; Jenny E Kootstra-Ros; Hiddo J L Heerspink; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart Journal: Biomolecules Date: 2020-03-21